Recovery of Nail Dystrophy: Potential New Therapeutic Indication of Tofacitinib

    February 2017 in “ Clinical rheumatology
    Jose A. Jaller, Juan José Jaller, Antonio M. Jaller, Juan J. Jaller-Char, Sineida Berbert Ferreira, Rachel Berbert Ferreira, Morton Scheinberg
    TLDR Tofacitinib may help treat nail dystrophy, especially when other treatments fail.
    The document reported that tofacitinib, a therapy initially developed for rheumatoid arthritis, showed potential benefits for patients with nail dystrophy, particularly those whose condition was resistant to conventional treatments. This finding suggested a new therapeutic indication for tofacitinib in treating nail diseases associated with autoimmune conditions like psoriasis and psoriatic arthritis.
    Discuss this study in the Community →

    Research cited in this study

    6 / 6 results

    Related Community Posts Join

    6 / 6 results

    Similar Research

    5 / 688 results